MX2011007732A - Formulacion de mycoplasma gallisepticum. - Google Patents

Formulacion de mycoplasma gallisepticum.

Info

Publication number
MX2011007732A
MX2011007732A MX2011007732A MX2011007732A MX2011007732A MX 2011007732 A MX2011007732 A MX 2011007732A MX 2011007732 A MX2011007732 A MX 2011007732A MX 2011007732 A MX2011007732 A MX 2011007732A MX 2011007732 A MX2011007732 A MX 2011007732A
Authority
MX
Mexico
Prior art keywords
strain
mycoplasma gallisepticum
bird
mycoplasma
gallisepticum
Prior art date
Application number
MX2011007732A
Other languages
English (en)
Spanish (es)
Inventor
Stanley H Kleven
Naola M Ferguson
Original Assignee
Univ Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia filed Critical Univ Georgia
Publication of MX2011007732A publication Critical patent/MX2011007732A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2011007732A 2009-01-22 2010-01-22 Formulacion de mycoplasma gallisepticum. MX2011007732A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14647209P 2009-01-22 2009-01-22
PCT/US2010/021749 WO2010085611A2 (en) 2009-01-22 2010-01-22 Mycoplasma gallisepticum formulation

Publications (1)

Publication Number Publication Date
MX2011007732A true MX2011007732A (es) 2011-11-04

Family

ID=42356391

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007732A MX2011007732A (es) 2009-01-22 2010-01-22 Formulacion de mycoplasma gallisepticum.

Country Status (9)

Country Link
US (1) US8668912B2 (https=)
EP (1) EP2389433B1 (https=)
JP (1) JP5642710B2 (https=)
KR (1) KR101715159B1 (https=)
CN (1) CN102292432B (https=)
BR (1) BRPI1006947B1 (https=)
CA (1) CA2749213C (https=)
MX (1) MX2011007732A (https=)
WO (1) WO2010085611A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2943219T4 (pl) * 2012-09-10 2022-08-22 Susan Szathmary Szczepionka do zapobiegania zakażeniu mykoplazmalnemu u ptactwa wodnego
CN106967829A (zh) * 2017-05-18 2017-07-21 隋兆峰 一种鉴别mg 6/85株的套式pcr检测方法
CN110218808B (zh) * 2019-06-28 2021-07-13 华中农业大学 滑液囊支原体和鸡毒支原体的四重pcr检测试剂盒
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗
US20260014240A1 (en) * 2022-07-20 2026-01-15 University Of Connecticut Rationally designed mycoplasma gallisepticum subunit vaccine
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196514A (en) 1990-03-06 1993-03-23 The University Of Georgia Research Foundation, Inc. Method of detecting mycoplasma infection in poultry and compositions therefor
WO1993001276A1 (en) 1991-07-12 1993-01-21 Smithkline Beecham Corporation Continuous cell line and vaccine against avian coccidia
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US7785822B2 (en) 2002-08-27 2010-08-31 University Of Georgia Research Foundation, Inc. Assays for the detection of biliverdin in birds and reptiles
US20070178115A1 (en) 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines

Also Published As

Publication number Publication date
HK1161289A1 (zh) 2012-08-24
BRPI1006947A2 (pt) 2016-10-04
CA2749213A1 (en) 2010-07-29
BRPI1006947B1 (pt) 2020-02-04
WO2010085611A2 (en) 2010-07-29
CA2749213C (en) 2017-08-15
KR20110123748A (ko) 2011-11-15
CN102292432B (zh) 2013-05-22
KR101715159B1 (ko) 2017-03-10
US8668912B2 (en) 2014-03-11
EP2389433A2 (en) 2011-11-30
WO2010085611A3 (en) 2010-11-25
CN102292432A (zh) 2011-12-21
EP2389433B1 (en) 2015-11-25
JP5642710B2 (ja) 2014-12-17
US20120021005A1 (en) 2012-01-26
JP2012515552A (ja) 2012-07-12
EP2389433A4 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
Salehi et al. Assessment of immunity against avian colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers
CN106947746B (zh) 鸡传染性支气管炎致弱疫苗株ldl-t株及其应用
CN102458462B (zh) 一种温度敏感的猪肺炎支原体疫苗株及其应用
US8668912B2 (en) Mycoplasma gallisepticum formulation
EP4504902A1 (en) Live mycoplasma gallisepticum vaccines
El Gazzar et al. Characterization of a ts-11–like Mycoplasma gallisepticum isolate from commercial broiler chickens
CN114854654B (zh) 一种肠炎沙门氏菌活疫苗
Throne Steinlage et al. Isolation and characterization of a 6/85-like Mycoplasma gallisepticum from commercial laying hens
Ferguson-Noel et al. Evaluation of Mycoplasma gallisepticum K-strain as a live vaccine in chickens
Abdelrahman et al. Avian Mycoplasma gallisepticum and Mycoplasma synoviae: advances in diagnosis and control. Ger
US20060257414A1 (en) Mycoplasma gallisepticum formulation
El-Hamid et al. Effect Of Mixed Experimental Infection With Gallibacterium Anatis And Mycoplasma Gallisepticum on Performance Of Broiler Chickens.
Pakpinyo et al. Efficacy and safety of different live Mycoplasma gallisepticum vaccines in layer chickens
HK1161289B (en) Mycoplasma gallisepticum formulation
Adamu et al. Evaluation of the protective efficacy of Salmonella Gallinarum 9R strain vaccine against Salmonella strains isolated from cases suspected of salmonellosis outbreaks in poultry farms in central Ethiopia
Vaino Molecular identification and antibiogram profiling of Avibacterium Paragallinarum and co-pathogenic bacteria assiciated with respiratory infections in chickens at Groot Aub settlement, Khomas region
Umar et al. Isolation of Mannheimia haemolytica from Layer Hens Showing Respiratory Signs.
Ferguson The evaluation of a live Mycoplasma gallisepticum vaccine candidate and DNA sequence analysis in the molecular epidemiology of Mycoplasma gallisepticum
Bamouh et al. Biological proprieties of Pasteurella multocida isolate from sheep in Morocco
Kassaye Adamu et al. Evaluation of the protective efficacy of Salmonella Gallinarum 9R strain vaccine against Salmonella strains isolated from cases suspected of salmonellosis outbreaks in poultry farms in central Ethiopia.
Armour An evaluation of the molecular epidemiology and transmission of avian mycoplasma genotypes in commercial poultry
Oliveira Haemophilus parasuis: diagnosis, epidemiology and control
Mathengtheng Molecular characterization of Mycoplasma gallisepticum strains from South African poultry
Limsatanun Development of inactivated mycoplasma gallisepticum vaccine in chickens

Legal Events

Date Code Title Description
FG Grant or registration